Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Press, news & insights

Latest article

DCPeloton returns for its third edition in 2027

18 September 2026

DCPeloton returns from 29 March to 5 April 2027, bringing IP professionals from around the world together in Flanders for a unique week of cycling, professional connections and Belgian culture.

Articles

Filter by
08 September 2026 General

Welcome to the team, Mathijs!

We are pleased to welcome Mathijs van Noort to De Clercq & Partners as a Patent Adviser / Trainee European Patent Attorney.

With his background in mathematics, engineering, computer science and AI, he will strengthen our Engineering, Software & AI team and contribute his expertise in areas including AI, software, IoT, medical devices, computer-implemented inventions, and various practical applications using software & AI.

We wish Mathijs a great start and look forward to working together!

08 September 2026 General | IP news | Patents

G1/25: Enlarged Board of Appeal Narrows Requirement to Adapt Patent Descriptions After Claim Amendments

The Enlarged Board of Appeal of the European Patent Office (EPO) has issued its long-awaited decision G 1/25 on 3 September 2026, clarifying when patent applicants and proprietors must adapt the description and drawings of a patent after amending the claims. We refer to our earlier articles of 16 March 2026  and 5 August 2025 on this subject. 

01 September 2026 Awards | General

Koen Vanhalst has once again been recognised in the IAM Strategy 300

We are pleased to announce that our partner Koen Vanhalst has once again been recognised in the IAM Strategy 300: The World’s Leading IP Strategists 2026.

The IAM Strategy 300 identifies leading professionals who are recognised for their ability to develop and implement strategies that maximise the value of intellectual property.

28 August 2026 General | IP news | Patents

The New EU Regulation on New Genomic Technique (NGT) Plants: What It Means for Patenting Plants in Europe

On June 17, 2026, the European Parliament adopted Regulation (EU) 2026/1388 on plants obtained by New Genomic Techniques (NGTs), which entered into force on July 16, 2026.

Negotiations for this new EU Regulation began after a CJEU decision in 2018, which ruled that plants obtained through targeted mutagenesis (such as the CRISPR-Cas9 gene-editing technique) were captured by the Regulation on genetically modified organisms (GMOs) and all the strict requirements that entails, despite the fact that such NGT plants (cisgenesis and targeted mutagenesis) scientifically differ from traditional GMOs (transgenesis) in that they do not necessarily contain “foreign DNA”.

12 August 2026 General | IP news | Trademarks

AI Act: Brussels Has Not Banned AI - It Has Simply Asked Us to Pay Attention

Anyone who still believes that artificial intelligence operates in a legal vacuum has probably spent the past two years somewhere without Wifi. The European AI Act is now very much with us and, since 2 August 2026, a number of its rules have become directly relevant to businesses that do not build AI systems, train foundation models or employ rooms full of data scientists. They simply use AI. In other words: almost everyone. 

14 July 2026 General | Patents

Anne-Lore Bex and Filip Van Lysebetten qualify as European Patent Attorneys

De Clercq & Partners is delighted to announce that Anne-lore Bex and Filip Van Lysebetten have successfully passed the European Qualifying Examination (EQE) and are now officially qualified as European Patent Attorneys.

Passing the EQE is a significant professional achievement, requiring extensive technical expertise, legal knowledge and years of dedicated preparation. As European Patent Attorneys, Anne-Lore and Filip are qualified to represent clients before the European Patent Office (EPO), providing strategic advice and guidance throughout the European patent process.